Title : Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells.

Pub. Date : 2008 Aug

PMID : 18496818






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. epigallocatechin gallate insulin Homo sapiens
2 Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. epigallocatechin gallate insulin Homo sapiens
3 In the present study, the investigations of EGCG on insulin signaling are performed in insulin-responsive human HepG2 cells cotreated with high glucose. epigallocatechin gallate insulin Homo sapiens
4 In the present study, the investigations of EGCG on insulin signaling are performed in insulin-responsive human HepG2 cells cotreated with high glucose. epigallocatechin gallate insulin Homo sapiens
5 However, the treatment of EGCG improves insulin-stimulated downsignaling by reducing IRS-1 Ser307 phosphorylation. epigallocatechin gallate insulin Homo sapiens
6 Together, our data suggest a putative link between high glucose and insulin resistance in HepG2 cells, and the EGCG treatment attenuates insulin signaling blockade by reducing IRS-1 Ser307 phosphorylation through the AMPK activation pathway. epigallocatechin gallate insulin Homo sapiens
7 Together, our data suggest a putative link between high glucose and insulin resistance in HepG2 cells, and the EGCG treatment attenuates insulin signaling blockade by reducing IRS-1 Ser307 phosphorylation through the AMPK activation pathway. epigallocatechin gallate insulin Homo sapiens